NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
LANDMARK BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LANDMARK BIO
ST13
US500000090981066Class
40, 42, 44
Filing
90981066
Registration
7475592
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/13/2024
Trademark type
Word
Nice classes
40, 42, 44
Filing date
07/06/2021
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-05-00
First use in commerce
2023-11-00
Drawing code
4
Owner type
99
Owner location
Watertown, MA
Examiner
DEFORD, JEFFREY
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
LANDMARK BIO, PBLLC
The Center for Advanced Biological Innovation and Manufacturing, PBLLC
Representatives
Jessica L. Rothstein GOODWIN PROCTER LLP
Technical classification
Nice Classes
Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Custom manufacturing of bio-pharmaceuticals and reagents for others; Bio-manufacturing for othersmanufacturing of pharmaceuticals and reagents using biological organisms and chemical synthesis in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing and bio-manufacturing; Consulting services in the field of manufacturing processes for pharmaceuticals and bio-pharmaceuticals
Class 42
Research and development of pharmaceuticals and bio-pharmaceuticals; research and development in the field of manufacturing processes for pharmaceuticals and bio-pharmaceuticals; technological servicestechnological consultation and research in the field of new product development in the pharmaceutical and health care industries; scientific analysis and researchevaluation of pharmaceutical products; scientific research and development with regard to medicines; product developmentpreparation of pharmaceutical test products; advisory services relating to scientific researchdevelopment and analyses of medicines and not for the diagnosis and treatment of humans or animals; development of new technologies in the biotechnology sector; providing information with regard to scientific research in the field of biochemistry and biotechnology; research and development of technologies used in manufacturingtesting and data analytics related bio-manufacturing; providing scientific information in the field of pharmaceutical manufacturing and bio-manufacturing
Class 44
Advisory services relating to analyses of medicines for the diagnosis and treatment of humans or animals
Publications
History of USPTO decisions and trademark events.
43 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/21/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/14/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/14/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/21/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
05/21/2024
EX2G
SOU EXTENSION 2 GRANTED
05/21/2024
IUAF
USE AMENDMENT FILED
04/03/2024
DRRR
DIVISIONAL REQUEST RECEIVED
04/03/2024
EXT2
SOU EXTENSION 2 FILED
04/03/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/03/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/14/2023
EX1G
SOU EXTENSION 1 GRANTED
10/13/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/13/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/11/2023
EXT1
SOU EXTENSION 1 FILED
10/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2023
PUBO
PUBLISHED FOR OPPOSITION
02/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2022
GNRT
NON-FINAL ACTION E-MAILED
12/05/2022
CNRT
NON-FINAL ACTION WRITTEN
12/05/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/28/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/28/2022
GNRT
NON-FINAL ACTION E-MAILED
03/28/2022
CNRT
NON-FINAL ACTION WRITTEN
03/28/2022
DOCK
ASSIGNED TO EXAMINER
03/24/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2021
NWAP
NEW APPLICATION ENTERED
07/09/2021
Continuous trademark protection
Get notified about every new filing that threatens LANDMARK BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.